Medication info
Telmiline 40mg (Telmisartan)

Telmiline 40mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
White oblong tablet
Packaging
30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle
Approval status
Active

MFDS item code 201908250 · Approved 2019.12.05 · Insurance code 663608530

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine provides an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease (myocardial infarction, stroke, etc.)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of damage to end organs in high-risk diabetes
  • myocardial infarction
View approved original text

This medicine helps control blood pressure in patients with essential hypertension. Additionally, it is used in patients aged 55 years or older with a high risk of cardiovascular disease to reduce the risk of myocardial infarction, stroke, and death due to cardiovascular diseases. It can be an effective treatment option, especially for those who find it difficult to take ACE inhibitors. Therefore, it plays a significant role in both hypertension management and reduction of cardiovascular disease risk.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine provides an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medicine can cause severe harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals allergic to this medication or its ingredients, pregnant or breastfeeding women, patients with severely impaired liver function, those with hereditary angioedema, and patients with certain renal diseases or diabetes. Elderly individuals or those with high potassium levels in the blood, liver or heart disease, or impaired kidney function require special caution when using this medication. While taking this medicine, regular checks of blood pressure, kidney function, and electrolyte levels are necessary to detect adverse reactions early and respond accordingly. Rarely, serious side effects such as angioedema, hyperkalemia, worsening of kidney function, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, so consult a healthcare professional immediately if such symptoms appear. When used in conjunction with other antihypertensive drugs, the blood pressure-lowering effect may be increased, and the risk of renal function impairment and hyperkalemia may be heightened, so caution is advised when combining therapies. Specifically, the concurrent use of this medication with ACE inhibitors or aliskiren is not recommended, and when used with lithium preparations, serum lithium levels should be monitored closely. It is advisable not to administer this medication within 24 hours prior to surgery, and overdose may cause hypotension, dizziness, and acute renal failure, necessitating immediate treatment. The safety and efficacy of this medication in children have not been established, so it is best avoided in pediatric use. When driving or operating machinery, caution is advised as dizziness or fainting may occur due to the effects of this medication.

Side effects

  • Upper respiratory tract infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 124 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distention
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug eruption
  • toxic skin eruption
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • increased liver enzymes
  • elevated blood creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • seizures
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • kidney failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • cough
  • abnormal chest X-ray
  • rhabdomyolysis
  • myalgia
  • weakness
  • increased myoglobin in blood and urine
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • palpitations
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • loss of appetite
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White oblong tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.